Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


2016 Review: Rapid Change Defines China Regulatory Environment

Executive Summary

If you missed some of the many significant events in China’s policy and regulatory landscape in 2016, here is your opportunity to catch up on month-by-month developments.

You may also be interested in...

Lucky Rooster? A Stellar Year Ahead For Chinese Pharma Investment

If the year of the Monkey is a jumpy ride filled with uncertainties, the coming year of the Rooster will be certain to bring more changes to the pharma sector and immuno-oncology, high-end devices and combining artificial intelligence with next-generation genomics are attracting large amount of hot cash inflow.

DTP Pharmacies March On In China: Pharma Ignores At Its Own Risk

A shift in dispensing from hospitals to external pharmacies has led to predictions that the direct-to-patient sales model will be big in China. But only those with the right partnerships and expertise will reap the benefits, leading pharmacy chain executives told a recent conference.

The ‘Sanming Model’: Bad Omen Or Hope For Pharma In China?

Pharma executives in China may soon get an earful of the name Sanming, as the populist healthcare reform model that began at the small city in Fujian is rolled out nationwide and impacts profoundly how drugs are tendered, priced and distributed.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts